Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation

Nature Medicine

Volumn 5, Issue 9, 1999, Pages 1010-1017

  Enjyoji, Keiichi ^a   Sévigny, Jean ^b   Lin, Yuan ^b   Frenette, Paul S ^b   Christie, Patricia D ^a   Am Esch II, Jan Schulte ^b   Imai, Masato ^b   Edelberg, Jay M ^a   Rayburn, Helen ^a   Lech, Miroslaw ^a   Beeler, David L ^a   Csizmadia, Eva ^b   Wagner, Denisa D ^b   Robson, Simon C ^b   Rosenberg, Robert D ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROLASE;

ANIMAL TISSUE; ARTICLE; BLEEDING TIME; BLOOD CLOTTING; FIBRIN DEPOSITION; GENE DISRUPTION; HEMOSTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; THROMBOCYTE ACTIVATION; THROMBOGENESIS;

ADENOSINE TRIPHOSPHATASES; ANIMALS; ANTIGENS, CD; APYRASE; ARTERIOLES; BLEEDING TIME; BLOOD COAGULATION; BLOOD PLATELETS; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FEMALE; FIBRIN; GENE DELETION; GRAFT REJECTION; HEART TRANSPLANTATION; HEMOSTASIS; MALE; MESENTERY; MICE; MICE, KNOCKOUT; PLATELET AGGREGATION; RATS; RECEPTORS, PURINERGIC P2; THROMBOPLASTIN; THROMBOSIS;

EID: 0345540629     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/12447     Document Type: Article

References (45)

1. Maliszewski, C.R. et al. The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization. J. Immunol. 153, 3574-3583 (1994).
2. 2+)apyrase. J. Biol. Chem. 271, 9898-9901 (1996).
3. Kaczmarek, E. et al. Identification and characterization of CD39/vascular ATP diphosphohydrolase. J. Biol. Chem. 271, 33116-33122 (1996).
4. Chadwick, B.P. & Frischauf, A.M. The CD39-like gene family-identification of three new human members (CD39L2, CD39L3, and CD39L4), their murine homologues, and a member of the gene family from Drosophila melanogoster. Genomics 50, 357-367 (1998).
5. Fijnheer, R. et al. Stored platelets release nucleotides as inhibitors of platelet function. Thromb. Haemost. 68, 595-599 (1992).
6. Heyns, A.d.P., Badenhorst, M. & Retief, F.P. ADPase activity of normal and atherosclerotic human aorta intima. Thromb. Haemost. 37, 429-435 (1977).
7. Coade, S.B. & Pearson, J.D. Metabolism of adenine nucleotides in human blood. Circ. Res. 65, 531-537 (1989).
8. Zimmermann, H. 5′-nucleotidase: molecular structure and functional aspects. Biochem. J. 285, 345-365 (1992).
9. Luthje, J. Origin, metabolism and function of extracellular adenine nucleotides in the blood. Klin. Wochenschr. 67, 317-27 (1989); erratum: 67, 558 (1989).
10. Fredholm, B.B. et al. Nomenclature and classification of purinoreceptors. Pharmocol. Rev. 46, 143-152 (1994).
11. Daniel, J.L. et al. Molecular basis for ADP-induced platelet activation I-evidence for three distinct ADP receptors on human platelets. J. Biol. Chem. 273, 2024-2029 (1998).
12. Jin, J.G., Daniel, J.L. & Kunapuli, S.P. Molecular basis for ADP-induced platelet activation II - the P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets J. Biol. Chem. 273, 2030-2034 (1998).
13. Dubyak, G.R. & Elmoatassim, C. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am. J. Physiol. 265,C 577-C 606 (1993).
14. Motte, S., Communi, D., Pirotton, S. & Boeynaems, J.M. Involvement of multiple receptors in the actions of extracellular ATP: the example of vascular endothelial cells. Int. J. Biochem. Cell Biol. 27, 1-7 (1995).
15. Marcus, A.J. & Safier, L.B. Thromboregulation: multicellular modulation of platelet reactivity in hemostasis and thrombosis. FASEB J. 7, 516-22 (1993).
16. Robson, S.C. et al. Loss of ATP diphosphohydrolase activity with endothelial cell activation, J. Exp. Med. 185, 153-163 (1997).
17. Schafer, A.I. Vascular endothelium-in defense of blood fluidity. J. Clin. Invest. 99, 1143-1144 (1997).
18. Denis, C. et al. A mouse model of severe von-Willebrand-disease-defects in hemostasis and thrombosis. Proc. Nat. Acad. Sci. USA 95, 9524-9529 (1998).
19. Berger, C., Hartwell, D.Q., Wagner, D.D. P-selectin and platelet clearance. Blood 92, 4446-4452 (1998).
20. Koyamada, N. et al. Apyrase administration prolongs discordant xenograft survival. Transplant 62, 1739-1743 (1996).
21. Jin, J.G. & Kunapuli S.P. Coactivation of two different C protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc. Nat. Acad. Sci. USA 95, 8070-8074 (1998).
22. Bach, F.H. et al. Delayed xenograft rejection. Immuml. Today 17, 379-384 (1996).
23. Siess, W. Molecular mechanisms of platelet activation. Physiol. Rev. 69, 58-178 (1989).
24. Shen, J., Gimbrone, M.A.J., Luscinkas, F.W. & Dewey, C.F.J. Regulation of adenine nucleotide concentration at endothelium-fluid interface by viscous shear flow. Biophys. J. 64, 1323-1330 (1993).
25. Sun, B., Li, J., Okahara, K. & Kambayashi, J. P2x(1) Purinoceptor in human platelets - molecular cloning and functional characterization after heterologous expression, J. Biol. Chem. 273, 11544-11547 (1998).
26. Weisman, G.A. et al. P2Y nucleotide receptors in the immune system: Signaling by a P2Y(2) receptor in U937 monocytes. Drug Dev. Res. 45, 222-228 (1998).
27. Weilerguettler, H. et al. A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state. J. Clin. Invest. 101, 1983-1991 (1998).
28. Von Albertini, M. et al. Extracellular ATP and ADP activate transcription factor NF-kappa-B and induce endothelial cell apoptosis. Biochem Biophys Res Commun 248, 822-829 (1998).
29. Deguchi H. et al. Adenosine regulates tissue factor expression on endothelial cells. Thromb. Res. 91, 57-64 (1998).
30. Bakker, W.W. et al. Experimental endotoxemia in pregnancy: in situ glomerular microthrombus formation associated with impaired glomerular adenosine diphosphatase activity. J. Lab. Clin. Med. 114, 531-537 (1989).
31. Yang, Z.H. et al. Different interactions of platelets with arterial and venous coronary bypass vessels. Lancet 337, 939-943 (1991).
32. Candinas, D. et al. Loss of rat glomerular ATP diphosphohydrolase activity during reperfusion injury is associated with oxidative stress reactions. Thromb. Haemost. 76, 807-812 (1996).
33. Gayle R.B. et al. Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39. J. Clin. Invest. 101, 1851-1859 (1998).
34. Sévigny, J., Levesque, F.P., Grondin, G. & Beaudoin, A.R. Purification of the blood vessel ATP diphosphohydrolase, identification and localization by immunological techniques. Biochim. Biophys. Acta. 1334, 73-88 (1997).
35. Baykov, A.A., Evtushenko, O.A. & Avaeva, S.M. A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay. Analyt. Biochem. 171, 266-270 (1988).
36. Bradford, M.M. A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254 (1976).
37. Liu, M.A. Overview of DNA vaccines. Ann. N.Y. Acad. Sci. 772, 15-20 (1995).
38. Towbin, H., Staehelin, T. & Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Procedure and some applications. Proc. Not. Acad. Sci. USA 76, 4350-4354 (1979).
39. Edelberg, J.M. et al. PDGF mediates cardiac microvascular communication. J. Clin. Invest. 102, 837-843 (1998).
40. Lundin, A., Richardsson A. & Thore, A. Continuous monitoring of ATP-converting reactions by purified firefly luciferase. Anal. Biochem. 75, 611-620 (1976).
41. Beurling-Harbury, C. & Harbury, P.B. Extraction of protein-bound ATP and ADP from human platelets in plasma. Thromb. Haemost. 63, 286-290 (1990).
42. Saito, H. et al. Plasma concentration of adenosine during normoxia and moderate hypoxia in humans. Am. J. Resp. Crit. Care Med. 159, 1014-1018 (1999).
43. Dejana, E., Callioni, A., Quintana, A. & de Gaetano, G. Bleeding time in laboratory animals. II - A comparison of different assay conditions in rats. Thromb. Res. 15, 191-197 (1979).
44. Johnson, E.N., Brass, L.F. & Funk, C.D. Increased platelet sensitivity to ADP in mice lacking platelet-type 12-lipoxygenase. Proc. Nat. Acad. Sci. USA 95, 3100-3105 (1998).
45. Koyamada, N. et al. Transient complement inhibition plus T-cell immunosuppression induces long-term survival of mouse-to-rat cardiac xenografts. Transplantation 65, 1210-1215 (1998).